Cargando…
Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years
INTRODUCTION: The Human T-lymphotropic virus type 1 (HTLV-1) was the first described human retrovirus. It is currently estimated that around 5 to 10 million people worldwide are infected with this virus. Despite its high prevalence, there is still no preventive vaccine against the HTLV-1 infection....
Autores principales: | Santana, Carolina Souza, Andrade, Felipe de Oliveira, da Silva, Greice Carolina Santos, Nascimento, Jéssica Oliveira de Souza, Campos, Raissa Frazão, Giovanetti, Marta, Santos, Luciane Amorim, Gois, Luana Leandro, Alcantara, Luiz Carlos Júnior, Barreto, Fernanda Khouri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968880/ https://www.ncbi.nlm.nih.gov/pubmed/36860854 http://dx.doi.org/10.3389/fimmu.2023.1073779 |
Ejemplares similares
-
An overview of sequencing technology platforms applied to HTLV-1 studies: a systematic review
por: de Oliveira Andrade, Felipe, et al.
Publicado: (2021) -
Seroprevalence of HTLV-1/2 among blood donors in the state of Maranhão, Brazil
por: de Castro Viana, Graça Maria, et al.
Publicado: (2014) -
ORFI genetic polymorphisms in geographically distinct HTLV-1 infections
por: Barreto, Fernanda Khouri, et al.
Publicado: (2015) -
Development of HTLV-1 Database for data management and datamining HTLV-1 sequences
por: Araujo, Thessika H A, et al.
Publicado: (2011) -
Consequences of the association between HTLV-1 and tuberculosis
por: de Lourdes Santana Bastos, Maria, et al.
Publicado: (2015)